>INVESTORS >Financial Highlights

Financial Highlights

Announced May 15, 2015

Consolidated operating results

(Billions of Yen)

FY12

FY13

FY14

vs. FY13

increase/

decrease

FY15

Forecasts

Revenue

1,557.0 1,691.7 1,777.8 86.1 5.1% 1,820.0

Overseas revenue

822.7 957.8 1,065.0 107.2 11.2% 1,130.0

<% of Revenue>

<52.8%> <56.6%> <59.9%> <3.3pt> <62.1%>

Revenue of ethical drugs segment

1,401.5 1,529.1 1,614.5 85.4 5.6% 1,670.0

R&D expenses

321.3 341.6 382.1 40.5 11.9% 330.0

<% of Revenue>

<20.6%> <20.2%> <21.5%> <1.3pt> <18.1%>

Operating profit

65.0 139.3 -129.3 -268.5 -192.8% 105.0

<% of Revenue>

<4.2%> <8.2%> <-7.3%> <-15.5pt> <5.8%>

Profit before income taxes

133.1 158.9 -145.4 -304.3 -191.6% 115.0

<% of Revenue>

<8.5%> <9.4%> <-8.2%> <-17.6pt> <6.3%>

Net profit for the year

150.7 109.6 -143.0 -252.6 -230.6%

<% of Revenue>

<9.7%> <6.5%> <-8.0%> <-14.5pt>

Profit attributable to owners of the Company

148.6 106.7 -145.8 -252.4 -236.7% 68.0

<% of Revenue>

<9.5%>  <6.3%> <-8.2%> <-14.5pt> <3.7%>

Core earnings *

285.5 314.2 288.3 -25.9 -8.2%

<% of Revenue>

<18.3%> <18.6%> <16.2%> <-2.4pt>
  • * Profit from regular business calculated by deducting any temporary factors such as impacts from business combination accounting and from amortization/impairment loss of intangible assets etc., from operating profit.

 

Consolidated financial position
(Billions of Yen) 

FY12 End

FY13 End

FY14 End

vs. FY13 End

Total assets 4,052.6 4,569.1 4,296.2 -273.0
Total liabilities 1,714.3 2,028.5 2,090.0 61.5
Total equity 2,338.3 2,540.6 2,206.2 -334.5
Equity attributable to owners of the Company 2,274.1 2,470.7 2,137.0 -333.7
Ratio of equity attributable to owners of the Company to total assets 56.1% 54.1% 49.7%  -4.3pt

 

SharesFY12 EndFY13 EndFY14 End
Numbers of Shares outstanding (1,000) 789,666 789,681 789,924
Treasury stock (1,000) 206 213 3,950
Stock price at year-end (Yen) 5,030 4,892 5,999
Total market value (Billions of Yen) 3,972.0 3,863.1 4,738.8
ROE/EPS/Dividend (Yen)

FY12

FY13

FY14

vs. FY13

Return on equity attributable to owners of the Company 6.8% 4.5% -6.3% -10.8pt
Basic earnings per share 188.21 135.10 -185.37 -320.47
Annual dividends per share 180.00 180.00 180.00 -
Dividend pay-out ratio 95.6% 133.2% -

 

Exchange rate (Yen)

FY12

FY13

FY14

FY15
Assumptions

US$ Average (Apr.-Mar.) 82 100 109 120 
Euro Average (Apr.-Mar.) 106 133 139 130 
 FY12FY13FY14
Number of employees (Consolidated) 30,481  31,225 31,328